RT Journal Article
SR Electronic
T1 First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e008668
DO 10.1136/jitc-2023-008668
VO 12
IS 7
A1 Wermke, Martin
A1 Holderried, Tobias A W
A1 Luke, Jason John
A1 Morris, Van K
A1 Alsdorf, Winfried H
A1 Wetzko, Katrin
A1 Andersson, Borje S
A1 Wistuba, Ignacio I
A1 Parra, Edwin R
A1 Hossain, Mohammad B
A1 Grund-Gröschke, Sandra
A1 Aslan, Katrin
A1 Satelli, Arun
A1 Marisetty, Anantha
A1 Satam, Swapna
A1 Kalra, Mamta
A1 Hukelmann, Jens
A1 Kursunel, M Alper
A1 Pozo, Karine
A1 Acs, Andreas
A1 Backert, Linus
A1 Baumeister, Melissa
A1 Bunk, Sebastian
A1 Wagner, Claudia
A1 Schoor, Oliver
A1 Mohamed, Ali S
A1 Mayer-Mokler, Andrea
A1 Hilf, Norbert
A1 Krishna, Delfi
A1 Walter, Steffen
A1 Tsimberidou, Apostolia M
A1 Britten, Cedrik M
YR 2024
UL http://jitc.bmj.com/content/12/7/e008668.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.